Pharma-Bio Serv, Inc. (PBSV) › Cash & EquivalentsPharma-Bio Serv, Inc. (PBSV) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $2.05M2010: $2.32M2011: $4.32M2012: $6.54M2013: $12.05M2014: $15.09M2015: $14.89M2016: $13.77M2017: $11.59M2018: $16.03M2019: $15.49M2020: $17.14M2021: $17.47M2022: $14.46M$14.46M2009Cash & Equivalents (USD)2022Fiscal YearCash & EquivalentsChange YoY2022$14.46M-17.2%2021$17.47M+1.9%2020$17.14M+10.6%2019$15.49M-3.4%2018$16.03M+38.3%2017$11.59M-15.8%2016$13.77M-7.5%2015$14.89M-1.3%2014$15.09M+25.3%2013$12.05M+84.2%2012$6.54M+51.5%2011$4.32M+86.3%2010$2.32M+12.9%2009$2.05M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share